Ultrasound-Mediated Blood–Brain Barrier Disruption and Drug Delivery

Dear Colleagues,

One of the greatest challenges in the treatment of neurological diseases is the limited delivery of therapeutics to the brain due to the blood–brain barrier (BBB). Recent technological evolution and refinement of focused ultrasound technology provides a novel opportunity to non-invasively disrupt the BBB and allow access to the brain. Current innovative research seeks to fully understand and therapeutically translate this novel modality to improve patient care.

This Special Issue, “Ultrasound-Mediated Blood–Brain Barrier Disruption and Drug Delivery”, aims to highlight recent and cutting-edge basic, translational, and clinical work in the field of focused ultrasound-mediated blood–brain barrier disruption and brain therapeutics.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

Basic, translational, and clinical research work on focused ultrasound-mediated blood–brain barrier disruption and drug delivery.

We look forward to receiving your contributions.

Dr. Manish Ranjan
Prof. Dr. Paul Lockman
Dr. Tasneem Arsiwala
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.